BioSpace News Archive

Titan Medical Seals Upsized $18M Funding Round

The funding round brought in nearly $4 million more than it was originally expecting.

December 6, 2017
·
1 min read
Policy

Abbott Maintains Nanostim Leadless Pacemaker Halt on Docking Button Issue

The 3.6mm docking button is designed to allow the Nanostim device to be retrieved after implantation.

December 6, 2017
·
1 min read
Policy

Medtronic Partner Mazor Robotics’ CEO Under Investigation for Insider Trading

The investigation dates back to a probe launched in May by Israel’s version of the U.S. SEC though the subject matter of the investigation was not initially revealed.

December 6, 2017
·
1 min read
Drug Development

ASIT Biotech Significantly Moves Forward in the Preparation of the Clinical Development Plan of gp-ASIT+ in the U.S.

ASIT biotech has received positive feedback from the FDA on the preparation of the clinical development plan for gp-ASIT+ in the U.S., with only a few comments and the request for some clarification on the Master File.

December 6, 2017
·
5 min read
Business

What You Need to Know About DMD Therapeutics

DMD Therapeutics is based in Seattle, although at present it is a virtual company, and, as its name suggests, is focused on developing therapeutics for DMD.

December 6, 2017
·
3 min read
·
Mark Terry
Business

What You Need to Know About Fibrocor Therapeutics

Based in Toronto, Ontario, Fibrocor Therapeutics was launched in January 2017.

December 6, 2017
·
5 min read
·
Mark Terry
Business

What You Need to Know About Fortis Therapeutics

Fortis Therapeutics is focused on immuno-oncology, specifically on developing an ADC for multiple myeloma and late-stage prostate cancer, including both the adenocarcinoma and neuroendocrine types.

December 6, 2017
·
3 min read
·
Mark Terry
Business

SoCal’s Avanir Axes 11% of Workforce

Avanir Pharmaceuticals will lay off 11 percent of its workforce by the end of January 2018 as part of a company restructuring.

December 6, 2017
·
2 min read
·
Alex Keown